Bailard’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-34,600
Closed -$434K 777
2022
Q3
$434K Hold
34,600
0.02% 388
2022
Q2
$266K Buy
34,600
+1,300
+4% +$10.9K 0.01% 522
2022
Q1
$337K Sell
33,300
-1,121
-3% -$10.2K 0.01% 500
2021
Q4
$249K Buy
+34,421
New +$188K 0.01% 603

Other funds holding SRTS

Bailard's SRTS Position: Q4 2022 in Review

Bailard sold out of Sensus Healthcare (SRTS) in Q4 2022, closing a stake of 34,600 shares — an estimated $434K sold.

Bailard first reported a position in SRTS in Q4 2021 and held it in 4 quarters. The position peaked at $434K in Q3 2022. 67 funds tracked by Wall St. Rank hold SRTS as of Q4 2022.

  • Bailard reported no remaining Sensus Healthcare position as of Q4 2022 after selling out during the quarter.
  • Bailard sold 34,600 Sensus Healthcare shares in Q4 2022, an estimated $434K.
  • Bailard first reported a position in Sensus Healthcare in Q4 2021 and held it in 4 quarters.
  • Bailard's Sensus Healthcare position peaked at $434K in Q3 2022.
  • 67 funds tracked by Wall St. Rank held Sensus Healthcare as of Q4 2022.

Based on Bailard's 13F filing for Q4 2022, filed 2 Feb 2023.